Physician profile
Stuart Jay Menn
NPI 1497775746
$943.01
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2020: $266 · 2021: $115 · 2022: $95.28 · 2023: $157 · 2024: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $363.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $194.95 | 2019-2024 | |
| Novo Nordisk INC | $118.46 | 2024 | Wegovy |
| Medtronic Vascular, INC. | $100.42 | 2020 | |
| Biogen, INC. | $96.72 | 2021 | |
| Boston Scientific Corporation | $93.66 | 2023 | Ams 700 |
| Harmony Biosciences LLC | $93.49 | 2020-2023 | Wakix |
| Teva Pharmaceuticals USA, INC. | $79.56 | 2022 | |
| Janssen Biotech, INC. | $71.80 | 2019 | |
| Inspire Medical Systems, INC. | $58.27 | 2023-2024 | Inspire |
| Philips North America LLC | $35.68 | 2019-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Menn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.